Quantcast

Latest Bacterial diseases Stories

2014-10-21 16:22:55

GRINNELL, Iowa and SCHAUMBURG, Ill., Oct. 21, 2014 /PRNewswire/ -- Grinnell Regional Medical Center (GRMC) is engaged with Olin Brass in a comprehensive clinical trial to test the impact of Olin Brass' CuVerro® solid copper alloy products. CuVerro is a bactericidal touch surface that kills 99.9 percent of bacteria* within two hours of contact. As an EPA-registered copper alloy surface, the properties of CuVerro® have been proven effective 24/7--continuously killing infectious...

2014-10-20 23:10:28

A point-of-use (POU) filter meets manufacturer’s claims for controlling Legionella for 62 days according to a study in the October issue of the American Journal of Infection Control released online. Pittsburgh, PA (PRWEB) October 20, 2014 A Legionella point-of-use (POU) filter meets manufacturer’s claims for controlling the bacteria for 62 days, according to the October issue of the American Journal of Infection Control released online. Special Pathogens Laboratory researchers, Janet...

2014-10-15 16:29:09

LONDON, Oct. 15, 30, 2014 /PRNewswire/ -- Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern. These infection may occur in a postoperative wound or as a complication unrelated to the disease or condition. This report, Healthcare-Associated Infection (HAI) Control Markets: focuses on the market opportunities for companies that can assist hospitals and other healthcare facilities with important HAI mitigation tasks...

2014-10-10 23:06:59

Aureus Medical Group, a nationwide leader in healthcare staffing, will be an exhibitor at the annual Occupational Therapy Association of California Conference to be held at the Pasadena Hilton & Pasadena Convention Center. Omaha, NE (PRWEB) October 10, 2014 Aureus Medical Group (web: aureusmedical.com), a national leader in healthcare staffing, including occupational therapy jobs, has announced that it will participate as an exhibitor at the OTAC 38th Annual Conference to be held...

Study Shows Hospitalized Patients Don't Wash Their Hands Enough
2014-10-09 03:57:16

Provided by McMaster University Hospital visitors and staff are greeted with hand sanitizer dispensers in the lobby, by the elevators and outside rooms as reminders to wash their hands to stop infections, but just how clean are patients' hands? A study led by McMaster University researcher Dr. Jocelyn Srigley has found that hospitalized patients wash their hands infrequently. They wash about 30 per cent of the time while in the washroom, 40 per cent during meal times, and only three...

2014-10-08 08:26:16

VIENNA and PHILADELPHIA, October 8, 2014 /PRNewswire/ -- Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin,...

2014-10-07 08:29:40

LAUSANNE, Switzerland, October 7, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, announced today excellent progress of its Phase I single and multiple ascending dose study of Debio 1450, a highly potent anti-infective agent selectively active against Staphylococcus species, including all known resistant strains such as...

2014-10-06 23:01:58

Topical report “Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014” worked out by Global Markets Direct is now available at MarketPublishers.com. London, UK (PRWEB) October 06, 2014 Hospital-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA) is potentially lethal strain of Staph aureus which is resistant to some antibiotics. This superbug has become a frequent guest in many medical facilities, representing a surging...

2014-10-06 08:28:03

Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct. 6, 2014 /PRNewswire/ -- Savara Pharmaceuticals announced today that it closed a $10 million bridge financing round to support the development of AeroVanc, the first inhaled antibiotic being developed to address the growing number of methicillin-resistant Staphylococcus aureus (MRSA) lung infections in people with cystic fibrosis (CF). Previous investors participated in the financing, and new investors include...

2014-10-02 23:12:07

Enrich Products is the first manufacturer of Copper Silver Ionization Systems to receive both EPA registration and NSF61 certification. Pittsburgh, PA (PRWEB) October 02, 2014 Enrich Products, Inc. the leading manufacturer in North America of Copper-Silver Ionization Systems, has recently received the NSF/ANSI 61 and 372 Certifications by NSF International (NSF 61 Certification is for health effects only and does not address the disinfection efficacy of the product). Copper Silver...


Latest Bacterial diseases Reference Libraries

0_cef863082995e6cb66fa4a692bf165a7
2011-04-28 16:37:36

Vibrio vulnificus is a species of Gram-negative, motile, curved, rod-shaped bacteria of the Vibrio Genus. Hollis et al. first reported it in 1976. It was given the name Beneckea vulnifica by Reichelt et al. in 1976 and in 1979 Vibrio vulnificus by Farmer. V. vulnificus is related to V. cholerae and is present in marine environments such as estuaries, brackish ponds, or coastal areas. It causes an infection often incurred after eating seafood, especially raw or undercooked oysters. It can...

72_f634c1b2916580c60814457a175ea810
2011-04-28 15:06:23

Vibrio cholerae is a gram negative comma-shaped bacterium with a polar flagellum that causes cholera in humans. V. cholerae belongs to the gamma subdivision of the Proteobacteria. Classical and El Tor are the two types of V. Cholerae identified by hemaggluttination testing. El Tor is found throughout the world, while the classical biotype is found only in Bangladesh. It was first isolated as the cause of cholera by Italian anatomist Filippo Pacini in 1854; however, this discovery was not...

0_1b337eb3ae50456f130e22153cc80436
2011-04-28 14:40:22

Streptococcus pyogenes is a spherical, Gram-positive bacterium is the cause of Group A streptococcal infections. It displays streptococcal group A antigen on its cell wall. When it is cultured on blood agar plates it produces large zones of beta-hemolysis. They are catalase-negative and in ideal conditions it has an incubation period of about 1-3 days. It is an infrequent part of the skin flora. It is the cause of many important human diseases, ranging from mild superficial skin infections...

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

0_86d2284273d6244c9ff290b35cdd2cf2
2011-04-25 21:24:26

Rickettsia rickettsii is a gram-negative bacterium native to the New World and causes the malady known as Rocky Mountain spotted fever (RMSF). It is transmitted through the bit of an infected tick when it feeds on animals and humans. Humans are not necessary hosts in the rickettsia-tick life cycle but they can be. S. Burt Wolbach created the first detailed description of the etiologic agent in 1919. He recognized it as an intracellular bacterium seen most frequently in endothelial cells....

More Articles (19 articles) »
Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related